Advertisement
Screener

KYMERA THERAPEUTICS, INC. (KYMR) Auditor

KYMERA THERAPEUTICS, INC. Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-02-26: Fiscal year end 2025-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Boston, Massachusetts.
  • 2025-02-27: Fiscal year end 2024-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Boston, Massachusetts.
  • 2024-02-22: Fiscal year end 2023-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Boston, Massachusetts.
  • 2023-02-23: Fiscal year end 2022-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Boston, Massachusetts.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-02-262025-12-31Ernst & Young LLP42Boston, MassachusettsYes
2025-02-272024-12-31Ernst & Young LLP42Boston, MassachusettsYes
2024-02-222023-12-31Ernst & Young LLP42Boston, MassachusettsYes
2023-02-232022-12-31Ernst & Young LLP42Boston, MassachusettsYes
2022-02-242021-12-31Ernst & Young LLP42Boston, MassachusettsNo
2021-03-112020-12-31Ernst & Young LLPBoston, Massachusetts

Similar stocks

Stock NameCountryMarket CapPE Ratio
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
REPLIGEN CORP (RGEN)United States$10.755B185.31
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
BIO-TECHNE Corp (TECH)United States$11.379B74.68
Twist Bioscience Corp (TWST)United States$11.540B-47.21
Immunovant, Inc. (IMVT)United States$7.028B-14.78
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
CG Oncology, Inc. (CGON)United States$6.095B-27.95
Scholar Rock Holding Corp (SRRK)United States$5.920B-16.37